IL160350A0 - A method for preparing liposome formulations with a predefined release profile - Google Patents

A method for preparing liposome formulations with a predefined release profile

Info

Publication number
IL160350A0
IL160350A0 IL16035002A IL16035002A IL160350A0 IL 160350 A0 IL160350 A0 IL 160350A0 IL 16035002 A IL16035002 A IL 16035002A IL 16035002 A IL16035002 A IL 16035002A IL 160350 A0 IL160350 A0 IL 160350A0
Authority
IL
Israel
Prior art keywords
release profile
liposome formulations
preparing liposome
predefined release
predefined
Prior art date
Application number
IL16035002A
Other languages
English (en)
Original Assignee
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co filed Critical Yissum Res Dev Co
Publication of IL160350A0 publication Critical patent/IL160350A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL16035002A 2001-09-06 2002-09-09 A method for preparing liposome formulations with a predefined release profile IL160350A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31718701P 2001-09-06 2001-09-06
PCT/IL2002/000745 WO2003032947A2 (en) 2001-09-06 2002-09-09 A method for preparing liposome formulations with a predefined release profile

Publications (1)

Publication Number Publication Date
IL160350A0 true IL160350A0 (en) 2004-07-25

Family

ID=23232510

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16035002A IL160350A0 (en) 2001-09-06 2002-09-09 A method for preparing liposome formulations with a predefined release profile

Country Status (7)

Country Link
US (2) US20060165766A1 (xx)
EP (1) EP1429726A2 (xx)
JP (1) JP2005505602A (xx)
AU (1) AU2002334358B2 (xx)
CA (1) CA2460209A1 (xx)
IL (1) IL160350A0 (xx)
WO (1) WO2003032947A2 (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2523413A1 (en) 2003-04-25 2004-11-11 The Penn State Research Foundation Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
US20050129753A1 (en) * 2003-11-14 2005-06-16 Gabizon Alberto A. Method for drug loading in liposomes
US7744920B2 (en) 2004-09-09 2010-06-29 Hadasit Medical Research Services & Development Limited Use of liposomal glucocorticoids for treating inflammatory states
US20080063702A1 (en) * 2004-09-09 2008-03-13 Yechezkel Barenholz Liposomal Formulations Comprising an Amphipathic Weak Base Like Tempamine for Treatment of Neurodegenerative Conditions
EP1802277B1 (de) 2004-10-18 2010-01-13 Polymun Scientific Immunbiologische Forschung GmbH Liposomale zusammensetzung einen wirkstoff zur relaxierung glatter muskulatur enthaltend, die herstellung dieser zusammensetzung und deren therapeutische verwendung
US20080213352A1 (en) * 2007-03-02 2008-09-04 Luna Innovations Incorporated Liposome carriers for in vivo delivery of fullerenes
DE102007036294A1 (de) 2007-07-31 2009-02-05 Gea Westfaliasurge Gmbh Vorrichtung und ein Verfahren zum Bereitstellen von Informationen über Tiere beim Durchlaufen eines Tierdurchganges
AU2009302042A1 (en) 2008-10-07 2010-04-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Liposomal systems comprising sphingomyelin
US20110223675A1 (en) * 2008-11-20 2011-09-15 Terumo Kabushiki Kaisha Drug release means from liposomes and method for evaluating releasability
US20100129430A1 (en) * 2008-11-24 2010-05-27 Stavroula Sofou Liposome drug carriers with ph-sensitivity
EP2630953B1 (en) * 2010-12-27 2017-08-09 Terumo Kabushiki Kaisha Liposome composition and process for production thereof
KR101494594B1 (ko) 2011-08-30 2015-02-23 주식회사 종근당 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
KR101586790B1 (ko) * 2012-12-28 2016-01-19 주식회사 종근당 음이온성 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
KR101586791B1 (ko) 2012-12-28 2016-01-19 주식회사 종근당 ＧｎＲＨ 유도체의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
FI3922241T3 (fi) 2013-02-01 2023-11-28 Celator Pharmaceuticals Inc Niukasti liukoisten lääkkeiden etälataus liposomeihin
WO2014121235A2 (en) * 2013-02-01 2014-08-07 Zoneone Pharma, Inc. Transformation of drug cyclodextrin complex compositions into compositions of mixtures of lipid vesicle encapsulated drug and cyclodextrin drug complexes
US20140271825A1 (en) * 2013-03-14 2014-09-18 Zoneone Pharma, Inc. Pharmaceutical formulations of chelating agents as a metal removal treatment system
CN106999419A (zh) 2014-08-04 2017-08-01 佐尼奥尼制药股份有限公司 远程装载略微水溶性药物至脂质膜泡
WO2018136002A1 (en) 2017-01-18 2018-07-26 Temasek Life Sciences Laboratory Limited Hyperstabilized liposomes increase targeting of mitotic cells
JP2020111523A (ja) * 2019-01-09 2020-07-27 国立研究開発法人理化学研究所 機能性ナノ構造体
GB202200962D0 (en) * 2022-01-25 2022-03-09 Cytoseek Ltd Polymer additives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1338702C (en) * 1987-03-05 1996-11-12 Lawrence D. Mayer High drug:lipid formulations of liposomal- antineoplastic agents
IL91664A (en) * 1988-09-28 1993-05-13 Yissum Res Dev Co Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release
US5972379A (en) * 1995-02-14 1999-10-26 Sequus Pharmaceuticals, Inc. Liposome composition and method for administering a quinolone
WO1996032930A1 (en) * 1995-04-18 1996-10-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem Liposome drug-loading method and composition
EP1105098B8 (en) * 1998-08-12 2007-10-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem Liposomal therapeutic compositions an ammonium sulphate gradient prepared using
EP1176962B1 (en) * 1999-04-29 2004-02-11 Alza Corporation Liposome compositions for improved drug retention

Also Published As

Publication number Publication date
CA2460209A1 (en) 2003-04-24
WO2003032947A2 (en) 2003-04-24
US20080213353A1 (en) 2008-09-04
JP2005505602A (ja) 2005-02-24
EP1429726A2 (en) 2004-06-23
WO2003032947A3 (en) 2003-09-25
US20060165766A1 (en) 2006-07-27
AU2002334358B2 (en) 2008-02-07

Similar Documents

Publication Publication Date Title
IL160350A0 (en) A method for preparing liposome formulations with a predefined release profile
EG24141A (en) Method for preparing a composition
IL194034A (en) Method for preparing o-desmethylvenlafaxine
EP1277787A4 (en) PROCESS FOR PREPARING A MICROSPHERE
HUP0104405A2 (en) Process for preparing imidachlopid
HUP0402208A3 (en) Kit for preparing a spread
HUP0400769A3 (en) Peroxyester preparation method
EP1245548A4 (en) PROCESS FOR THE MANUFACTURE OF VITROCERAMIC
HUP0301649A3 (en) Process for preparing azacycloalkanoylaminothiazoles
HUP0300114A3 (en) Process for preparing flavonoid-derivatives
IL150043A0 (en) Method for preparing bromodifluoroacetic compounds
HUP0201837A3 (en) Process for preparation n-carboxy-anhydrides
IL158124A0 (en) Leishmania vaccines
EP1298117A3 (en) Method for preparing bromofluorenes
EP1429732A4 (en) CORE FORMULATION
HUP0303638A3 (en) Method for producing a vaccine
AU4663601A (en) Method for preparing 9-deoxo-8a-aza-(8a-alkyl)-8a-homoerythromycin derivativesfrom 9-deoxo-9(z)-hydroxyiminoerythromycin
EP1340494A4 (en) PROCESS FOR PREPARING A MICROSOME DISPERSION
AU2003298519A8 (en) Methods for preparing a solid-fibrin web
GB0130297D0 (en) A mould
HUP0401401A3 (en) Method for preparing 7-quinolinyl-3,5-dihydroxyhept-6-enoate
HU0204443D0 (en) Process for preparing fluoroformates
EP1451178A4 (en) PROCESS FOR PREPARING BEAT D RIBOFURANOSE DERIVATIVES
IL143999A0 (en) Method for preparing a diamond
GB0109275D0 (en) A method for preparing radiolabelled methylene blue